Johnson & Johnson JNJ reported second-quarter earnings of $2.58 per share, which beat the analyst consensus estimate of $2.43. This is a 22.86% increase over earnings of $2.1 per share from the same period last year.
The company reported quarterly sales of $20.56 billion, which beat the analyst consensus estimate of $20.29 billion. This is a 1.30% decrease over sales of $20.83 billion the same period last year.
Johnson & Johnson reaffirms 2019 adjusted EPS guidance of $8.53-$8.63 versus $8.60 estimates.
Johnson & Johnson's stock traded higher by 0.9% at $135.95 in Tuesday's pre-market session. The stock has a 52-week high of $148.99 and a 52-week low of $121
Related Links:
Johnson & Johnson Falls On Report Of Justice Department Probe
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.